维普期刊资源整合服务平台（V6.5）

113篇 您的检索式：作者名="TOSONI A"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	A phase Ⅱ, randomized, non-comparative clinical trial of the effect of bevaeizumab (BV) alone or in combination with irinotecan (CPT) on 6-month progression free survival ( PFS6 ) in recurrent, treatment-refractory glioblastoma (GBM)显示文摘	Brandes AA Tosoni A Basso U	2008	J Clin Oncol2008，26，20：	1
2	Recurrencepattern after temozolomide concomitant with and adjuvantto radiotherapy in newly diagnosed patients with glioblas-toma :correlation With MGMT promoter methylation sta-tus显示文摘	Brandes AA Tosoni A Franceschi E	2009	J Clin Oncol2009，27，8：	1
3	Prognostic factors for anaplastic astrocytomas 显示文摘	Compostella A Tosoni A Blatt V	2007	J Neurooncol2007，81，3：	1
4	Bevacizumab in brain tumors: ready for primetime ? 显示文摘	Franceschi E Tosoni A Girardi F	2009	Future Oneol2009，5，8：	1
5	Long-term results of a prospective study on the treatment of medulloblastoma in adults 显示文摘	Brandes AA Franceschi E Tosoni A	2007	Cancer2007，110，：	1
6	Prognostic factors for anaplastic astrocytomas 显示文摘	Compostella A Tosoni A Blatt V	2007	Neuro - Oncol2007，81，3：	1
7	Epidermal growth factor re- ceptor inhibitors in neuro-oncology: hopes and disappointments 显示文摘	Brandes AA Franceschi E Tosoni A	2008	Clin Cancer Res2008，14，4：	1
8	Formation of symmetric azo- compounds from primary aromatic amines by lead tet- rancetate显示文摘	Baer E Tosoni A L	1956	Journal of American Chemistry Socie- ty1956，78，12：	1
9	Prognostic factors for anaplastic astrocytomas显示文摘	Compostella A Tosoni A Blatt V	2007	J Neurooncol2007，81，3：	1
10	Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition显示文摘	Guarino M Tosoni A Nebuloni M	2009	Hum Pathol2009，40，10：	1
11	MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemothcrapy in newly diagnosed gtioblastoma patients 显示文摘	Brandes AA Franceschi E Tosoni A	2008	J Clin Oncol2008，26，13：	1
12	Prognostic factors for anaplastic astrocytomas显示文摘	Compostella A A Tosoni V Blatt	2007	J Neurooncol2007，81，3：	1
13	MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients显示文摘	Brandes A A Franceschi E Tosoni A	2008	J Clin Oncol2008，26，13：	1
14	Synthesis of novel chiral Ionic liquids and their phase behavior in mixtures with smectic and nematic liquid crystals 显示文摘	TOSONI M LASCHAT S BARO A	2004	Helv Chim Acta2004，87，：	1
15	Treatment op- tions for recurrent glioblastoma: pitfalls and future trends 显示文摘	Franceschi E Tosoni A Bartolini S	2009	Expert Rev Anticancer Ther2009，9，5：	1
16	The pathogenesis and treatment of brain metastases:A comprehensive review显示文摘	Tosoni A Ermani M Brandes AA	2004	Crit Rev Oncol Hematol2004，52，3：	1
17	Fotemustine as second- line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase Ⅱ trial of Gruppo haliano Cooperativo di Neuro-Oncologia ( GICNO ) 显示文摘	Brandes AA Tosoni A Franceschi E	2009	Cancer Chemother Pharmacol2009，64，：	1
18	Prognostic factors for anaplastic astrocytomas显示文摘	Compostella A Tosoni A Blatt V	2007	J Neurooncol2007，81，3：	1
19	Direct contribution of epithelium to organ fibrosis: epithelial -mesenchymal transition显示文摘	Guarino M Tosoni A Nebuloni M	2009	Hum Pathol2009，40，10：	1
20	MGMT promoter methylation status can predict the inci- dence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma pa- tients显示文摘	BRANDES A A FRANCESCHI E TOSONI A	2008	J Clin Oncol2008，26，13：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示